These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33099292)

  • 1. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway.
    Wu Q; Zheng J; Dou C; Qi S
    Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression.
    Kim H; Park KJ; Ryu BK; Park DH; Kong DS; Chong K; Chae YS; Chung YG; Park SI; Kang SH
    Neuropathol Appl Neurobiol; 2020 Feb; 46(2):125-141. PubMed ID: 31179553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.
    Talari NK; Panigrahi MK; Madigubba S; Phanithi PB
    J Neurooncol; 2018 Apr; 137(2):241-248. PubMed ID: 29302888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis.
    Lu H; Kang F
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas.
    Leclair NK; Lucas CG; Mirchia K; McCortney K; Horbinski CM; Raleigh DR; Anczukow O
    Acta Neuropathol; 2024 Aug; 148(1):28. PubMed ID: 39179895
    [No Abstract]   [Full Text] [Related]  

  • 8. FDI-6, a FOXM1 inhibitor, activates the aryl hydrocarbon receptor and suppresses tumorsphere formation.
    Yamashita N; Kawai K; Yoshikawa M; Watabe M; Kanno Y; Sanada N; Kizu R
    Biochem Biophys Res Commun; 2023 Jan; 639():29-35. PubMed ID: 36463758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells.
    Han H; Davidson LA; Fan YY; Goldsby JS; Yoon G; Jin UH; Wright GA; Landrock KK; Weeks BR; Wright RC; Allred CD; Jayaraman A; Ivanov I; Roper J; Safe SH; Chapkin RS
    EMBO J; 2020 Oct; 39(19):e104319. PubMed ID: 32915464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
    Wang W; Guo Z; Yu H; Fan L
    J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.
    Vasudevan HN; Braunstein SE; Phillips JJ; Pekmezci M; Tomlin BA; Wu A; Reis GF; Magill ST; Zhang J; Feng FY; Nicholaides T; Chang SM; Sneed PK; McDermott MW; Berger MS; Perry A; Raleigh DR
    Cell Rep; 2018 Mar; 22(13):3672-3683. PubMed ID: 29590631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis.
    Ye Y; Xu L; Zhang L; Zhao P; Cai W; Fu G; Wang T; Tao Z; Shi W; Gu W; Hu J; Yuan G; Wei Y; Xu K; Bao Z; Chao H; Liu N; Zhao L; Tu Y; Ji J
    Redox Biol; 2024 Jun; 72():103137. PubMed ID: 38642502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.
    Fan SY; Jiang JD; Qian J; Lu YC; Hu GH; Luo C; Hou WD; Wang Q
    PLoS One; 2015; 10(5):e0125661. PubMed ID: 25993541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
    Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
    J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
    Jiang C; Song T; Li J; Ao F; Gong X; Lu Y; Zhang C; Chen L; Liu Y; He H; Huang O
    Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.
    Yin J; Sheng B; Pu A; Han B; Yang K; Wang Q; Sun L; Yang H
    Dig Dis Sci; 2016 Feb; 61(2):444-52. PubMed ID: 26514676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
    J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly established patient-derived organoid model of intracranial meningioma.
    Yamazaki S; Ohka F; Hirano M; Shiraki Y; Motomura K; Tanahashi K; Tsujiuchi T; Motomura A; Aoki K; Shinjo K; Murofushi Y; Kitano Y; Maeda S; Kato A; Shimizu H; Yamaguchi J; Adilijiang A; Wakabayashi T; Saito R; Enomoto A; Kondo Y; Natsume A
    Neuro Oncol; 2021 Nov; 23(11):1936-1948. PubMed ID: 34214169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway.
    Yan J; Hou J; Yan Y; Ren XY; Luo HN; Wang ZG; Zheng GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6786-6793. PubMed ID: 32633370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.